Precigen (PGEN) EBT Margin (2012 - 2026)
Precigen (PGEN) posted quarterly EBT Margin of 34.1% for Q1 2026, up 400415.0% year-over-year from N/an in Q1 2025, and up 88.59% quarter-over-quarter from 298.79% in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) EBT Margin (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported EBT Margin for 15 consecutive years, with 34.1% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 400415.0% year-over-year to 34.1%; the TTM figure through Mar 2026 stood at 622.44% (up 213307.0% YoY), while the FY2025 annual figure was 2588.18%, up 67368.0% from the prior year.
- EBT Margin grew to 34.1% in Q1 2026 per PGEN's latest filing, from 298.79% in the prior quarter.
- Across five years, EBT Margin topped out at 152.41% in Q4 2022 and bottomed at 2396600.0% in Q3 2024.
- Historically, EBT Margin has averaged 276020.43% across 5 years, with a median of 1692.62% in 2023.
- Annual changes were most pronounced in 2023 — EBT Margin sank 198004739 bps — and 2025, when it jumped 238106454 bps.
- Precigen's EBT Margin stood at 152.41% in 2022, then slumped by 1884 bps to 2718.89% in 2023, then surged by 80 bps to 536.96% in 2024, then soared by 44 bps to 298.79% in 2025, then jumped by 89 bps to 34.1% in 2026.
- Business Quant data shows PGEN's EBT Margin at 34.1% in Q1 2026, 298.79% in Q4 2025, and 15535.46% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 36.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.51% |
| Mar 31, 2026 | -34.10% |
| Dec 31, 2025 | -514.85% |
| Sep 30, 2025 | -5,008.35% |
| Jun 30, 2025 | -3,112.03% |
| Mar 31, 2025 | -4,038.26% |
| Dec 31, 2024 | -1,665.04% |
| Sep 30, 2024 | -2,514.80% |
| Jun 30, 2024 | -8,435.29% |
| Mar 31, 2024 | -2,231.64% |
| Dec 31, 2023 | -2,718.89% |
| Sep 30, 2023 | -1,435.90% |
| Jun 30, 2023 | -1,153.59% |
| Mar 31, 2023 | -1,231.17% |
| Dec 31, 2022 | -1,257.40% |
| Sep 30, 2022 | -46.01% |
| Jun 30, 2022 | -898.25% |
| Mar 31, 2022 | -434.54% |
| Dec 31, 2021 | -724.35% |
| Sep 30, 2021 | -791.48% |